Lamivudine News and Research

RSS
New guidelines for antiretroviral drugs to prevent the transmission of HIV from mothers to their children

New guidelines for antiretroviral drugs to prevent the transmission of HIV from mothers to their children

AIDS Healthcare Foundation targets GSK over voluntary licensing of its AIDS drug patents in South Africa

AIDS Healthcare Foundation targets GSK over voluntary licensing of its AIDS drug patents in South Africa

GSK and Boehringer Ingelheim to develop treatment for HIV infection specifically for the developing world

GSK and Boehringer Ingelheim to develop treatment for HIV infection specifically for the developing world

Comparison of antiretroviral therapies shows that tenofovir DF and stavudine are equally effective

Comparison of antiretroviral therapies shows that tenofovir DF and stavudine are equally effective

Inexpensive generic fixed-dose combined therapies appears the most suitable solution for treating AIDS in developing countries

Inexpensive generic fixed-dose combined therapies appears the most suitable solution for treating AIDS in developing countries

Generic fixed-dose combinations (FDCs) of antiretrovirals are a key factor in access to treatment of HIV/AIDS infection in the developing world

Generic fixed-dose combinations (FDCs) of antiretrovirals are a key factor in access to treatment of HIV/AIDS infection in the developing world

Access to HIV antiretroviral therapies in the developing world should be a major world health priority

Access to HIV antiretroviral therapies in the developing world should be a major world health priority

WHO removes two antiretroviral products from the WHO List of prequalified products

WHO removes two antiretroviral products from the WHO List of prequalified products

Weekly cycles of once-daily anti-HIV drugs could reduce cost of HIV treatment

Weekly cycles of once-daily anti-HIV drugs could reduce cost of HIV treatment

Weekly cycles of once-daily anti-drugs could reduce cost of HIV treatment

Weekly cycles of once-daily anti-drugs could reduce cost of HIV treatment